Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage
- PMID: 27863512
- PMCID: PMC5116193
- DOI: 10.1186/s13075-016-1156-1
Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage
Abstract
Background: We investigated two distinct synovial fibroblast populations that were located preferentially in the lining or sub-lining layers and defined by their expression of either podoplanin (PDPN) or CD248, and explored their ability to undergo self-assembly and transmigration in vivo.
Methods: Synovial fibroblasts (SF) were cultured in vitro and phenotypic changes following stimulation with interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β1 were examined. To examine the phenotype of SF in vivo, a severe combined immunodeficiency (SCID) human-mouse model of cartilage destruction was utilised.
Results: SF in the lining layer in rheumatoid arthritis (RA) expressed high levels of PDPN compared to the normal synovium, whereas CD248 expression was restricted to sub-lining layer cells. TNF-α or IL1 stimulation in vitro resulted in an increased expression of PDPN. In contrast, stimulation with TGF-β1 induced CD248 expression. In the SCID human-mouse model, rheumatoid SF recapitulated the expression of PDPN and CD248. Fibroblasts adjacent to cartilage expressed PDPN, and attached to, invaded, and degraded cartilage. PDPN+ CD248- SF preceded the appearance of PDPN- CD248+ cells in contralateral implants.
Conclusions: We have identified two distinct SF populations identified by expression of either PDPN or CD248 which are located within different anatomical compartments of the inflamed synovial membrane. These markers discriminate between SF subsets with distinct biological properties. As PDPN-expressing cells are associated with early fibroblast migration and cartilage erosion in vivo, we propose that PDPN-expressing cells may be an attractive therapeutic target in RA.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5116193/bin/13075_2016_1156_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5116193/bin/13075_2016_1156_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5116193/bin/13075_2016_1156_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5116193/bin/13075_2016_1156_Fig4_HTML.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5116193/bin/13075_2016_1156_Fig5_HTML.gif)
Similar articles
-
CD248 and its cytoplasmic domain: a therapeutic target for arthritis.Arthritis Rheum. 2010 Dec;62(12):3595-606. doi: 10.1002/art.27701. Arthritis Rheum. 2010. PMID: 20722022
-
Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis.Arthritis Rheum. 2004 May;50(5):1468-76. doi: 10.1002/art.20218. Arthritis Rheum. 2004. PMID: 15146416
-
The SCID mouse model: novel therapeutic targets - lessons from gene transfer.Springer Semin Immunopathol. 2003 Aug;25(1):65-78. doi: 10.1007/s00281-003-0126-2. Springer Semin Immunopathol. 2003. PMID: 12904892 Review.
-
[Rheumatoid arthritis: new developments in the pathogenesis with special reference to synovial fibroblasts].Z Rheumatol. 2001 Oct;60(5):309-18. doi: 10.1007/s003930170030. Z Rheumatol. 2001. PMID: 11759230 Review. German.
-
Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.Arthritis Res. 2000;2(1):59-64. doi: 10.1186/ar69. Arthritis Res. 2000. PMID: 11219390 Free PMC article.
Cited by
-
Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis.Arthritis Res Ther. 2024 May 23;26(1):103. doi: 10.1186/s13075-024-03343-4. Arthritis Res Ther. 2024. PMID: 38783357 Free PMC article. Review.
-
Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development.F1000Res. 2024 Jan 10;13:54. doi: 10.12688/f1000research.143472.1. eCollection 2024. F1000Res. 2024. PMID: 38681509 Free PMC article. Review.
-
Cellular characterisation of advanced osteoarthritis knee synovium.Arthritis Res Ther. 2023 Aug 23;25(1):154. doi: 10.1186/s13075-023-03110-x. Arthritis Res Ther. 2023. PMID: 37612718 Free PMC article.
-
Inflammatory Mesenchymal Stem Cells Express Abundant Membrane-Bound and Soluble Forms of C-Type Lectin-like CD248.Int J Mol Sci. 2023 May 31;24(11):9546. doi: 10.3390/ijms24119546. Int J Mol Sci. 2023. PMID: 37298499 Free PMC article.
-
Locus-specific induction of gene expression from heterochromatin loci during cellular senescence.Nat Aging. 2022 Jan;2(1):31-45. doi: 10.1038/s43587-021-00147-y. Epub 2021 Dec 23. Nat Aging. 2022. PMID: 37118356
References
-
- Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 2000;43:259–269. doi: 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous